• News
  • Contact Us

Ellen Chang, Sc.D.

Managing Scientist

Epidemiology & Computational Biology

Professional Profile


Dr. Chang has more than 13 years of experience in the design, conduct, analysis, interpretation, and publication of health research studies, with a particular focus on studies of cancer, immunologic disorders, and infectious diseases. She has expertise in selecting and recruiting research participants, designing and implementing surveys, collecting and storing biological specimens, managing large datasets, and analyzing and interpreting statistical data. She has published more than 100 peer-reviewed research articles and reviews, and 5 book chapters.

Prior to joining Exponent, Dr. Chang was a Research Scientist at the Cancer Prevention Institute of California, where she helped to lead risk and survival studies of cancers of the head and neck, nasopharynx, stomach, liver, lung and bronchus, skin, breast, uterus, ovary, prostate, thyroid, and lymphatic system. These studies focused on a wide range of exposures including genetic variation, physical activity, body size, diet and nutrition, alcohol consumption, tobacco smoking, ultraviolet radiation, immunologic biomarkers, microbial infections, use of nonsteroidal anti-inflammatory drugs and other medications, use of hormone therapy and oral contraceptives, reproductive factors, medical history, family structure, and demographic characteristics. In addition, Dr. Chang was the Chief Epidemiologist at the Asian Liver Center at Stanford University, where she conducted community-based research on hepatitis B and liver cancer awareness, detection, prevention, and medical management. She continues to be affiliated with the Stanford Cancer Institute and the Division of Epidemiology in the Department of Epidemiology at the Stanford University School of Medicine.

Dr. Chang earned her undergraduate degree in English and American literature and language from Harvard College. She earned her Sc.D. (Doctor of Science) in epidemiology with a minor in biostatistics from the Harvard School of Public Health. Her doctoral research focused on the role of immunologic and infectious risk factors in the development of Hodgkin lymphoma. Dr. Chang completed a post-doctoral fellowship at Karolinska Institutet in Stockholm, Sweden, where she conducted case-control, cohort, and registry-based research studies of non-Hodgkin and Hodgkin lymphomas, prostate cancer, nasopharyngeal carcinoma, and rheumatoid arthritis.

  • Sc.D., Epidemiology, Harvard University, 2003
  • A.B., English and American Literature and Language, Harvard University, 1998
  • National Cancer Institute Minority Investigators Workshop on Behavioral Methodologies Fellowship, 2007
  • New York Academy of Sciences (NYAS) Science Alliance Program Membership, 2005–2006
  • National Institutes of Health Ruth L. Kirschstein National Research Service Award, 2004–2005
  • American Association for the Advancement of Science (AAAS)/Science Program for Excellence in Science Membership, 2004–2005
  • Harvard University Sheldon Traveling Fellowship, 2003–2004
  • Harvard School of Public Health Department of Epidemiology Seiden Scholarship, 2001–2003
  • Harvard University Pforzheimer Public Service Fellowship, 1999–2003
  • National Cancer Institute/Harvard School of Public Health Cancer Epidemiology Pre-Doctoral Training Program Fellowship, 1998–2002

    • Consulting Assistant Professor, Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, 2007–present

  • Mandarin